424 related articles for article (PubMed ID: 32978861)
1. Preparing for COVID-19 vaccine safety surveillance: A United States perspective.
Haynes K
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1529-1531. PubMed ID: 32978861
[No Abstract] [Full Text] [Related]
2. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.
Bikdeli B; Chatterjee S; Arora S; Monreal M; Jimenez D; Krumholz HM; Goldhaber SZ; Elkind MSV; Piazza G
J Am Coll Cardiol; 2021 Jul; 78(4):408-411. PubMed ID: 34116145
[No Abstract] [Full Text] [Related]
3. General determination of causation between Covid-19 vaccines and possible adverse events.
Hampton LM; Aggarwal R; Evans SJW; Law B
Vaccine; 2021 Mar; 39(10):1478-1480. PubMed ID: 33558107
[No Abstract] [Full Text] [Related]
4. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 vaccine fast facts.
Kolber MR; Fritsch P; Price M; Singer AG; Young J; Dugré N; Bradley S; Nickonchuk T
Can Fam Physician; 2021 Mar; 67(3):185-186. PubMed ID: 33727379
[No Abstract] [Full Text] [Related]
6. Global covid-19 vaccine rollout and safety surveillance-how to keep pace.
Lo Re V; Klungel OH; Chan KA; Panozzo CA; Zhou W; Winterstein AG
BMJ; 2021 Jun; 373():n1416. PubMed ID: 34144957
[No Abstract] [Full Text] [Related]
7. Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US.
Weiss SR
JAMA; 2022 May; 327(20):2019-2020. PubMed ID: 35608592
[No Abstract] [Full Text] [Related]
8. Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
Oster ME; Shay DK; Shimabukuro TT
JAMA; 2022 May; 327(20):2020-2021. PubMed ID: 35608588
[No Abstract] [Full Text] [Related]
9. Monitoring Vaccine Adverse Event Reporting System (VAERS) Reports Related to COVID-19 Vaccination Efforts in Rhode Island.
Karayeva E; Kim HW; Bandy U; Clyne A; Marak TP
R I Med J (2013); 2021 Sep; 104(7):64-66. PubMed ID: 34437669
[No Abstract] [Full Text] [Related]
10. Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.
Hause AM; Baggs J; Gee J; Marquez P; Myers TR; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(39):1379-1384. PubMed ID: 34591835
[TBL] [Abstract][Full Text] [Related]
11. Information on COVID-19 vaccines and vaccinations.
Kohl S
Eur J Hosp Pharm; 2021 Mar; 28(2):120-122. PubMed ID: 33608444
[No Abstract] [Full Text] [Related]
12. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.
Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Blanc PG; Gwira Baumblatt JA; Woo EJ; Gee J; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(7):249-254. PubMed ID: 35176008
[TBL] [Abstract][Full Text] [Related]
13. Being fair to participants in placebo-controlled COVID-19 vaccine trials.
Dal-Ré R; Orenstein W; Caplan AL
Nat Med; 2021 Jun; 27(6):938. PubMed ID: 33903751
[No Abstract] [Full Text] [Related]
14. The Missing Link in the Covid-19 Vaccine Race.
Zizzo J
Hum Vaccin Immunother; 2021 May; 17(5):1326-1328. PubMed ID: 33079612
[TBL] [Abstract][Full Text] [Related]
15. Large US Study Examines First 6 Months of COVID-19 Vaccine Safety Data.
Abbasi J
JAMA; 2022 Apr; 327(14):1323. PubMed ID: 35412579
[No Abstract] [Full Text] [Related]
16. COVID-19 in the elderly people and advances in vaccination approaches.
Dhama K; Patel SK; Natesan S; Vora KS; Iqbal Yatoo M; Tiwari R; Saxena SK; Singh KP; Singh R; Malik YS
Hum Vaccin Immunother; 2020 Dec; 16(12):2938-2943. PubMed ID: 33270497
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune and auto-inflammatory adverse events after COVID-19 vaccination in the United States.
Kim SJ; Rhee TG; Shim SR
Clin Immunol; 2024 Feb; 259():109882. PubMed ID: 38158168
[TBL] [Abstract][Full Text] [Related]
18. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
Vitiello A; Ferrara F; Troiano V; La Porta R
Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
[TBL] [Abstract][Full Text] [Related]
20. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.
Oliver SE; Gargano JW; Scobie H; Wallace M; Hadler SC; Leung J; Blain AE; McClung N; Campos-Outcalt D; Morgan RL; Mbaeyi S; MacNeil J; Romero JR; Talbot HK; Lee GM; Bell BP; Dooling K
MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(9):329-332. PubMed ID: 33661860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
